Trial site
Farkasgyepui Tudogyogyintezet
- 14running trials
- 8closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer21 trials
- Bronchiectasis1 trial
- COPD1 trial
- Cystic fibrosis1 trial
- Phase
- Phase 316 trials
- Phase 24 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Recruiting10 trials
- Completed7 trials
- Active, not recruiting4 trials
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Bristol-Myers Squibb3 trials
- Amgen2 trials
- Eli Lilly and Company2 trials
- Merck Sharp & Dohme LLC2 trials
- Mirati Therapeutics Inc.2 trials
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Recruiting
Recruiting
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer10 recruiting
Closed trials
Recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Active, not recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026